2.0
8. Aug. 2024
Ehem. befristeter Mitarbeiter, weniger als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Can't think of anything at this time.
Kontras
This company acquired Fluxion Biosciences and ran it into the ground. Subsequently, there's been a massive exodus—the company likely has less than 6 months of runway